Stem Cell Implants Aim to Restore Dopamine in Parkinson’s Disease

Doctors test brain cell implants to restore movement in Parkinson’s

Scientists at Keck Medicine of USC are testing an experimental stem cell therapy that aims to restore the brain’s ability to produce dopamine, the chemical whose loss drives Parkinson’s disease. The early-stage clinical trial involves implanting lab-grown dopamine-producing cells directly into a key movement-control region of the brain, with the hope of slowing disease progression and improving motor function.

Stem cell brain implants aim to replace dopamine cells in Parkinson's trial

Parkinson's disease is a progressive neurodegenerative disorder that affects more than one million people in the United States, with approximately 90,000 new cases diagnosed each year. Although available treatments can help manage symptoms, there is currently no cure or therapy proven to slow the progression of the disease.

A new stem cell treatment could offer hope for people living with Parkinson’s

More than 1 million Americans live with the neurodegenerative brain disorder – and that number is expected to climb

Stem cell implants aim to restore dopamine in Parkinson’s disease

Parkinson's disease is a progressive neurodegenerative disorder that affects more than one million people in the United States, with approximately 90,000 new cases diagnosed each year.

Breakthrough Stem Cell Therapy Shows Promise for Parkinson’s Disease

Parkinson’s disease represents one of the most challenging neurodegenerative conditions affecting the global population, with an incidence exceeding one million individuals in the United States alone. Each year, approximately 90,000 new cases are diagnosed, underscoring the urgent need for therapeutic innovations. While current treatments primarily focus on symptomatic relief, there remains a conspicuous absence of effective interventions capabl…

New Stem Cell Treatment May Offer Hope for Parkinson’s Disease

Keck Medicine of USC is conducting an early phase clinical trial investigating the safety and effectiveness of implanting specialized stem cells into the brain that have been programmed to replace damaged brain cells and produce dopamine.